Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
Elizabeth A. Thompson(Bloomberg (United States)), Jonathan D. Powell(Bloomberg (United States)), Richard E. Rothman(Johns Hopkins University), Hongkai Ji(Johns Hopkins University), Weiqiang Zhou(Johns Hopkins University), Evan M. Bloch(Johns Hopkins University), Alvaro A. Ordoñez(Johns Hopkins University), Avi Z. Rosenberg, Nathan Brady(University Hospital Heidelberg), Ajay Vaghasia(Sidney Kimmel Comprehensive Cancer Center), Franco R. D’Alessio(Pulmonary and Critical Care Associates), Michael J. Delannoy(Johns Hopkins University), Im‐Hong Sun(Bloomberg (United States)), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Institute for Transfusion Medicine), Anne Hamacher‐Brady(Scripps Research Institute), Kellie N. Smith(Bloomberg (United States)), Srinivasan Yegnasubramanian(Johns Hopkins Medicine), Andrew D. Redd(Johns Hopkins University), Andrea L. Cox(Johns Hopkins University), Rulin Wang(Sidney Kimmel Comprehensive Cancer Center), Maureen Horton(Johns Hopkins University), Katherine Fenstermacher(Johns Hopkins University), Lauren Sauer(Johns Hopkins University), Katherine Cascino(Johns Hopkins University)
Cited by 135
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k